Edition:
United States

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

9.05USD
4:00pm EDT
Change (% chg)

$0.25 (+2.84%)
Prev Close
$8.80
Open
$8.75
Day's High
$9.18
Day's Low
$8.75
Volume
53,794
Avg. Vol
108,257
52-wk High
$12.50
52-wk Low
$3.47

Chart for

About

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): $657.70
Shares Outstanding(Mil.): 55.40
Dividend: --
Yield (%): --

Financials

  ABUS.OQ Industry Sector
P/E (TTM): -- 28.28 30.39
EPS (TTM): -2.23 -- --
ROI: -51.57 12.94 12.61
ROE: -55.72 14.96 14.80

BRIEF-Arbutus Announces Corporate Update

* ARBUTUS ANNOUNCES CORPORATE UPDATE AND YEAR-END 2017 FINANCIAL RESULTS

Mar 14 2018

BRIEF-Arbutus Settles Litigation Terminating Acuitas Rights To LNP Technology

* ARBUTUS SETTLES LITIGATION, TERMINATING ACUITAS’ RIGHTS TO LNP TECHNOLOGY

Feb 22 2018

Earnings vs. Estimates